Key Highlights:
- Exclusive MENAT rights for 21 premium international healthcare and pharmaceutical brands.
- Diversified portfolio spanning consumer healthcare, prescription medicines, aesthetics, nutrition, and medical devices.
- Scalable expansion plan from UAE & KSA into GCC, North Africa, and Turkey.
- Robust infrastructure with GDP-compliant warehousing, 17+ locations, and 20+ sub-distributor partnerships.
- Experienced leadership team with 50+ years in MENAT healthcare and strong projected growth ($9.7M+ revenue by 2026).
